Equities

Stereotaxis Inc

Stereotaxis Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.26
  • Today's Change0.41 / 22.16%
  • Shares traded992.09k
  • 1 Year change+53.74%
  • Beta1.4970
Data delayed at least 15 minutes, as of Nov 12 2024 23:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

  • Revenue in USD (TTM)23.75m
  • Net income in USD-22.08m
  • Incorporated1990
  • Employees122.00
  • Location
    Stereotaxis Inc710 N Tucker Blvd, Ste 110ST. LOUIS 63101United StatesUSA
  • Phone+1 (314) 678-6100
  • Fax+1 (314) 678-6159
  • Websitehttps://www.stereotaxis.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sensus Healthcare Inc36.37m6.65m115.54m35.0017.322.1816.833.180.40720.40722.233.230.66011.102.651,039,057.0012.0610.2913.2512.1460.2362.8518.2715.298.20--0.00---45.20-1.58-98.00---23.16--
TELA Bio Inc64.74m-42.11m115.80m227.00--25.28--1.79-1.71-1.712.640.11630.83761.487.62285,215.80-54.48-52.00-66.54-60.9568.6165.32-65.04-107.652.52-8.690.9343--41.1347.85-5.35---17.12--
908 Devices Inc.52.69m-37.99m125.46m230.00--0.8018--2.38-1.15-1.151.604.520.25111.544.95229,069.60-18.11-14.16-20.12-15.3552.3253.02-72.10-64.254.23--0.00--7.2117.89-8.45--22.98--
KORU Medical Systems Inc30.82m-11.76m132.29m82.00--7.07--4.29-0.2574-0.25740.67420.40820.97372.946.50375,817.30-37.15-17.60-43.48-20.2962.4959.44-38.16-21.703.27--0.0195--2.2310.44-58.65--11.10--
Myomo Inc25.24m-8.38m148.20m101.00--15.95--5.87-0.2294-0.22940.68470.30721.513.118.08249,892.40-50.25-81.78-81.40-115.2770.0368.50-33.22-85.761.62--0.00--23.7051.0924.00--2.82--
EUDA Health Holdings Ltd3.81m-17.99m150.70m106.00------39.54-0.4821-0.44510.1487-0.16851.86--7.2135,957.55-876.41------22.05---472.08-----43.68-----1.54--66.17------
Pro-Dex Inc56.80m5.21m154.30m148.0030.935.0624.152.721.531.5316.349.361.092.484.64383,770.3010.0312.3312.3515.3028.2531.269.1712.131.945.310.3040.0016.8314.66-69.93-12.47-6.80--
Stereotaxis Inc23.75m-22.08m156.61m122.00--13.52--6.60-0.265-0.2650.2850.2020.56321.145.04194,639.30-49.21-25.02-71.93-34.1259.2867.57-87.38-41.901.53--0.00---4.89-1.82-12.33--6.63--
Alpha Tau Medical Ltd0.00-27.63m157.33m121.00--2.13-----0.3966-0.39660.001.060.00----0.00-26.66---28.28--------------0.0681------13.64------
Acme United Corp190.49m19.52m157.85m645.008.551.477.320.82874.944.9446.9028.771.182.095.84295,331.7012.137.0914.258.2939.3735.7210.255.501.917.060.233718.81-1.276.88486.3131.089.024.84
Akoya Biosciences Inc93.22m-60.35m159.39m330.00--7.16--1.71-1.22-1.221.890.44980.56051.936.34282,472.70-36.29---45.98--57.57---64.74--1.98-8.000.7755--29.09--10.36------
Cibus Inc2.96m-291.86m169.87m183.00--0.4892--57.37-16.39-16.390.154511.750.0043--3.0916,180.33-53.70-86.28-64.26-96.45-----12,400.74-792.07---2.660.0032--1,057.3350.41-1,484.44--18.53--
SANUWAVE Health Inc24.90m-3.43m191.17m31.00------7.68-3.55-3.558.17-12.561.243.908.34803,064.50-17.07-136.54----71.5769.13-13.79-189.600.09990.1199----21.8461.61-150.72------
Senseonics Holdings Inc24.04m-80.46m191.66m132.00--299.50--7.97-0.1323-0.13230.03950.07140.18152.585.99182,113.60-60.74-73.65-74.52-106.9712.04-40.41-334.69-649.862.89-10.930.5802--36.623.43-142.49---18.76--
InfuSystem Holdings Inc129.37m366.00k193.12m499.00578.543.6115.411.490.01570.01575.992.511.2210.386.44259,264.500.34654.600.4015.6949.6856.430.28294.071.641.970.38980.0014.4413.384,744.44--6.01--
Data as of Nov 12 2024. Currency figures normalised to Stereotaxis Inc's reporting currency: US Dollar USD

Institutional shareholders

39.96%Per cent of shares held by top holders
HolderShares% Held
DAFNA Capital Management LLCas of 01 Jul 202413.68m16.16%
Lagoda Investment Management LPas of 30 Jun 20243.95m4.67%
BlackRock Fund Advisorsas of 30 Jun 20243.27m3.86%
The Vanguard Group, Inc.as of 30 Jun 20242.93m3.46%
Arbiter Partners Capital Management LLCas of 20 Aug 20242.77m3.27%
Redmile Group LLCas of 30 Jun 20242.11m2.49%
Archon Capital Management LLCas of 30 Jun 20241.60m1.89%
Essex Investment Management Co. LLCas of 30 Sep 20241.41m1.67%
Geode Capital Management LLCas of 30 Jun 20241.30m1.53%
Prescott Group Capital Management LLCas of 30 Sep 2024823.65k0.97%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.